VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $99,792 | -83.5% | 23,100 | -74.8% | 0.00% | -100.0% |
| Q2 2023 | $605,002 | +59.1% | 91,806 | +63.9% | 0.00% | 0.0% |
| Q1 2023 | $380,254 | -67.2% | 56,002 | -64.3% | 0.00% | -66.7% |
| Q4 2022 | $1,158,656 | -32.3% | 156,787 | -9.5% | 0.00% | -25.0% |
| Q3 2022 | $1,712,000 | -24.8% | 173,288 | -17.1% | 0.00% | -33.3% |
| Q2 2022 | $2,277,000 | +20.3% | 208,927 | +24.9% | 0.01% | +50.0% |
| Q1 2022 | $1,893,000 | -27.9% | 167,342 | 0.0% | 0.00% | -20.0% |
| Q4 2021 | $2,626,000 | -3.6% | 167,342 | +5.3% | 0.01% | 0.0% |
| Q3 2021 | $2,723,000 | -13.3% | 158,869 | +8.8% | 0.01% | -16.7% |
| Q2 2021 | $3,141,000 | +33.7% | 146,009 | -6.7% | 0.01% | +20.0% |
| Q1 2021 | $2,350,000 | +417.6% | 156,475 | +353.2% | 0.01% | +400.0% |
| Q4 2020 | $454,000 | +35.9% | 34,524 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $334,000 | -15.4% | 34,524 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $395,000 | +10.3% | 34,524 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $358,000 | -36.9% | 34,524 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $567,000 | +23.3% | 34,524 | -0.4% | 0.00% | 0.0% |
| Q3 2019 | $460,000 | -5.7% | 34,654 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $488,000 | -23.1% | 34,654 | +0.4% | 0.00% | -50.0% |
| Q1 2019 | $635,000 | -29.9% | 34,514 | -0.5% | 0.00% | -33.3% |
| Q4 2018 | $906,000 | +13.8% | 34,674 | 0.0% | 0.00% | +50.0% |
| Q3 2018 | $796,000 | +20.4% | 34,674 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $661,000 | +15.4% | 34,674 | +1.9% | 0.00% | 0.0% |
| Q1 2018 | $573,000 | +10.8% | 34,024 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $517,000 | -15.1% | 34,024 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $609,000 | +9.7% | 34,024 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $555,000 | -63.2% | 34,024 | -68.4% | 0.00% | -50.0% |
| Q1 2017 | $1,509,000 | -12.2% | 107,768 | 0.0% | 0.00% | -20.0% |
| Q4 2016 | $1,719,000 | -11.3% | 107,768 | -7.5% | 0.01% | -16.7% |
| Q3 2016 | $1,939,000 | +93.3% | 116,503 | +30.0% | 0.01% | +100.0% |
| Q2 2016 | $1,003,000 | +35.0% | 89,624 | +0.9% | 0.00% | 0.0% |
| Q1 2016 | $743,000 | -10.2% | 88,844 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $827,000 | -41.6% | 88,844 | -29.2% | 0.00% | -40.0% |
| Q3 2015 | $1,416,000 | -17.3% | 125,498 | -7.1% | 0.01% | -16.7% |
| Q2 2015 | $1,713,000 | +375.8% | 135,022 | +249.0% | 0.01% | +500.0% |
| Q1 2015 | $360,000 | -38.9% | 38,684 | -6.0% | 0.00% | -50.0% |
| Q4 2014 | $589,000 | +37.0% | 41,134 | -0.7% | 0.00% | +100.0% |
| Q3 2014 | $430,000 | -35.8% | 41,436 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $670,000 | -0.1% | 41,436 | +0.4% | 0.00% | 0.0% |
| Q1 2014 | $671,000 | +29.0% | 41,278 | -1.5% | 0.00% | 0.0% |
| Q4 2013 | $520,000 | +13.0% | 41,888 | 0.0% | 0.00% | +100.0% |
| Q3 2013 | $460,000 | +36.1% | 41,888 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $338,000 | – | 41,888 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |